NanoViricides

$3.84
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.04 (-1.03%) As of 2:06 PM EDT today

Why Robinhood?

You can buy or sell NanoViricides and other stocks, options, and ETFs commission-free!

About NNVC

NanoViricides Inc., also called NanoViricides, is a development stage company, which engages in the development of nanomedicine drugs against viruses. It focuses on anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs. Read More The company was founded by Anil R. Diwan on April 1, 2005 and is headquartered in Shelton, CT. The listed name for NNVC is NanoViricides Inc.

Employees
17
Headquarters
Shelton, Connecticut
Founded
2005
Market Cap
40.91M
Price-Earnings Ratio
Dividend Yield
Average Volume
136.05K
High Today
$3.90
Low Today
$3.69
Open Price
$3.90
Volume
74.46K
52 Week High
$19.20
52 Week Low
$1.85

Collections

NNVC Earnings

-$1.24
-$0.83
-$0.41
$0.00
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Q4 2020
Q1 2021
Estimated
per share
Actual
Expected Nov 13, After Hours

You May Also Like